ABG Analytics logo
 

Amgen Inc (NASDAQ: AMGN)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 02/16/2024
Closing price: 283.70
Support price level: $272.45
Resistance price level: $298.64
Relative strength index (14-day RSI) 24.9
Beta 0.27
  • AMGN is one of this month's worst performers with a return of -7.8%, underperforming 90 percent of stocks in the S&P-100.

  • Volatility is forecast to fall over the next month.

  • AMGN is above its 200-day moving average, providing a measure of support for long positions.

  • With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.

Low High Price as % of Range
$214.27 $324.56 67.6%
200 day 50 day 20 day 10 day
$260.87 $295.81 $305.27 $296.76
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
25.3% 20.3% 28.6% 26.2%
There is an estimated 5% probability that the stock price of Amgen Inc will fall by more than:
  • 7.8% in the next week.

  • 14.8% in the next month.

  • 42.2% in the next year.